Zydus Cadila

NASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for…

The drug firm has also received final approval from US health regulator for Desonide Cream, used to treat a variety of skin…

The EIR report stated that the classification of the facility is "No Action Indicated (NAI)", the company added

The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for…

As per a report prepared by the IPA, at its current rate of seven to eight per cent CAGR, the Indian pharmaceutical industry is…

The drug will be manufactured at group's formulations manufacturing facility at SEZ, Ahmedabad

The drug is used to treat schizophrenia and the manic symptoms of bipolar disorder, has received US FDA approval

The drug will be manufactured at the groups formulations manufacturing facility at pharma SEZ in Ahmedabad

Both drugs to be manufactured at the company’s formulations manufacturing facility at the Pharma SEZ, Ahmedabad

ZYAN1 has been shown to improve iron mobilisation and has the potential to reduce or eliminate the need for iron supplementation